Muscarinic responses of gastric parietal cells
- 1 June 1991
- journal article
- Published by Springer Nature in The Journal of Membrane Biology
- Vol. 122 (2) , 97-110
- https://doi.org/10.1007/bf01872634
Abstract
Isolated rabbit gastric glands were used to study the nature of the muscarinic cholinergic responses of parietal cells. Carbachol (CCh, 100 μm) stimulation of acid secretion, as measured by the accumulation of aminopyrine, was inhibited by the M1 antagonist, pirenzepine, with an IC50 of 13 μm; by the M2 antagonist, 11,2-(diethylamino)methyl-1 piperidinyl acetyl-5,11-dihydro-6H-pyrido 2,3-b 1,4 benzodiazepin-6-one (AF-DX 116), with an IC50 of 110 μm; and by the M1/M3 antagonist, diphenylacetoxy-4-methylpiperidinemethiodide (4-DAMP), with an IC50 of 35nm. The three antagonists displayed equivalent IC50 values for the inhibition of carbachol-stimulated production of14CO2 from radiolabeled glucose, which is a measure of the turnover of the H,K-ATPase, the final step of acid secretion. Intracellular calcium levels were measured in gastric glands loaded with FURA 2. Carbachol was shown to both release calcium from an intracellular pool and to promote calcium entry across the plasma membrane. The calcium entry was inhibitable by 20 μm La3+. The relative potency of the three muscarinic antagonists for inhibition of calcium entry was essentially the same as for inhibition of acid secretion or pump related glucose oxidation. Image analysis of the glands showed the effects of carbachol, and of the antagonists, on intracellular calcium were occurring largely in the parietal cell. The rise in cell calcium due to release of calcium from intracellular stores was inhibited by 4-DAMP with an IC50 of 1,7nm, suggesting that the release pathway was regulated by a low affinity M3 muscarinic receptor or state; Ca entry and acid secretion are regulated by a high affinity M3 muscarinic receptor or state, inhibited by higher 4-DAMP concentrations (>30nm), suggesting that it is the steady-state elevation of Ca that is related to parietal cell function rather than the [Ca] i transient. Displacement of3H N-methyl scopolamine (NMS) binding to purified parietal cells by CCh showed the presence of two affinities for CCh, but only a single affinity for 4-DAMP and lower affinity for pirenzepine and AFDX 116, providing further evidence for the parietal cell location of the [Ca] i response. Elevation of steady-state [Ca] i levels with either ionomycin or arachidonic acid did not replicate M3 stimulation of acid secretion or glucose oxidation, hence elevation of [Ca] i is necessary but not sufficient for acid secretion.Keywords
This publication has 41 references indexed in Scilit:
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990
- Muscarinic receptor differentiationPharmacology & Therapeutics, 1988
- Cloned rat M3 muscarinic receptors mediate phosphoinositide hydrolysis but not adenylate cyclase inhibitionFEBS Letters, 1988
- Release of intracellular Ca2+ and elevation of inositol trisphosphate by secretagogues in parietal and chief cells isolated from rabbit gastric mucosaBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- Differential effects of extracellular calcium removal and nonspecific effects of Ca2+ antagonists on acid secretory activity in isolated gastric glandsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
- Gastrin - Histamine as a Normal Sequence in Gastric Acid Stimulation in the RabbitUpsala Journal of Medical Sciences, 1979
- The Interaction of Histamine with Gastrin and Carbamylcholine on Oxygen Uptake by Isolated Mammalian Parietal CellsJournal of Clinical Investigation, 1978
- Effects of Secretagogues on Oxygen Consumption, Aminopyrine Accumulation and Morphology in Isolated Gastric GlandsActa Physiologica Scandinavica, 1976
- A Method for Preparing Isolated Glands from the Rabbit Gastric MucosaActa Physiologica Scandinavica, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973